Chronic Ingestion of Flavan-3-ols and Isoflavones Improves Insulin Sensitivity and Lipoprotein Status and Attenuates Estimated 10-Year CVD Risk in Medicated Postmenopausal Women Wi...

by Curtis, Peter J., Sampson, Mike, Potter, John, Dhatariya, Ketan, Kroon, Paul A., Cassidy, Aedín
Published 2012

Pro-oxidant effect of α-tocopherol in patients with Type 2 Diabetes after an oral glucose tolerance test – a randomised controlled trial

by Winterbone, Mark S, Sampson, Mike J, Saha, Shikha, Hughes, Jackie C, Hughes, David A
Published 2007

Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes

by Worley, Joanna R, Hughes, David A, Dozio, Nicoletta, Gavrilovic, Jelena, Sampson, Mike J
Published 2007

Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetes

by Sampson, Mike, Davies, Isabel, Gavrilovic, Jelena, Sussams, Brendan, Brown, Jackie, Astley, Sian, Hughes, David A
Published 2004

Monocyte matrix metalloproteinase production in Type 2 diabetes and controls – a cross sectional study

by Baugh, Mark D, Gavrilovic, Jelena, Davies, Isabel R, Hughes, David A, Sampson, Mike J
Published 2003

Comment on: Draznin et al. Pathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action. Diabetes Care 2013;36:1807–1814

by Dhatariya, Ketan, Sampson, Mike, Walton, Chris, Rayman, Gerry, Walden, Esther, Kelly, Tracy
Published 2013